Clinical Trials Browser

Withdrawn × Cytomegalovirus Infections × Clear all

NCT05589844 2023-04-27

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Phase 1 Withdrawn

Cytomegalovirus Infections

NCT04183738 2020-11-10

i2-D²EFT

Phase 4 Withdrawn

Acquired Immunodeficiency Syndrome, Cytomegalovirus Infections, Inflammation, Opportunistic Infections, Epstein-Barr Virus Infections, Coinfection